Sees FY24 Adjusted EBITDA guidance increased to a range of $17 to $19 million
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on THTX:
- Theratechnologies to present data at IDWeek 2024 on HIV managemet
- THTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Theratechnologies Braces for Supply Disruption
- Theratechnologies Faces EGRIFTA SV Supply Disruption
- Theratechnologies announces risk of temporary supply disruption for EGRIFTA SV